Clinical Trials · NCT03811574

STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity

Name: STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Semaglutide

Phase: Phase 3
Recruitment status: Completed
Sponsor: Novo Nordisk A/S
Enrollment: 401
Start date: Jan 2019
Locations: 28 sites, Japan, South Korea
Primary endpoint: Change in Body Weight (%)

View Semaglutide compound reference